This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

SMIC Donates 2 Million Chinese Yuan To Fund Liver Transplants For Disadvantaged Children





SHANGHAI, April 12, 2013 /PRNewswire/ -- Semiconductor Manufacturing International Corporation (" SMIC"; NYSE: SMI; SEHK: 981), China's largest and most advanced semiconductor foundry, today announced a donation of 2 million Chinese Yuan (including 400,000 Chinese Yuan in individual donations) to the China Soong Ching Ling Foundation to fund liver transplants for impoverished children at Renji Hospital (affiliated with Jiao Tong University School of Medicine) in Shanghai.

Liver transplantation is the only effective treatment for children with end-stage liver disease, but the procedure still presents many societal, economic and surgical challenges in China. As most children requiring liver transplantation reside in remote areas lacking adequate prenatal care, SMIC initiated the "SMIC Liver Transplant Program for Children" to provide afflicted children the opportunity for a new life, and to draw attention to their needs from the local community.

At the donation ceremony, Dr. TY Chiu, CEO of SMIC, presented a check to the China Soong Ching Ling Foundation. "Children are the hope of every family and the future of society," he said. "Funding a liver transplant not only saves a child, it helps a family and benefits society as a whole. SMIC always participates actively in charitable events and we are committed to fulfilling our corporate social responsibility to build a more harmonious society."

Li Weipin, Director of Renji Hospital said, "We are grateful to SMIC for helping children in need undergo liver transplant surgery at Renji Hospital. Renji Hospital has earned a reputation in China as a leader in pediatric liver transplant surgery. By working with a number of charities to build a fundraising platform for children with end-stage liver disease, Renji has successfully completed liver transplant surgeries for more than 90 children. In the future, Renji Hospital will continue to provide the most advanced liver transplant surgeries for underprivileged children with end-stage liver disease so that more children can grow up healthy."

About SMICSemiconductor Manufacturing International Corporation ("SMIC"; NYSE: SMI; SEHK: 981) is one of the leading semiconductor foundries in the world and the largest and most advanced foundry in mainland China, providing integrated circuit (IC) foundry and technology services at 0.35-micron to 40-nanometer. Headquartered in Shanghai, China, SMIC has a 300mm wafer fabrication facility (fab) and a 200mm mega-fab in Shanghai, a 300mm mega-fab in Beijing, a 200mm fab in Tianjin, and a 200mm fab project under development in Shenzhen. SMIC also has customer service and marketing offices in the U.S., Europe, Japan, and Taiwan, and a representative office in Hong Kong. For more information, please visit www.smics.com. Safe Harbor Statements(Under the Private Securities Litigation Reform Act of 1995)This press release contains, in addition to historical information, "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995.  These forward-looking statements are based on SMIC's current assumptions, expectations and projections about future events.  SMIC uses words like "believe," "anticipate," "intend," "estimate," "expect," "project" and similar expressions to identify forward-looking statements, although not all forward-looking statements contain these words.  These forward-looking statements involve significant risks, both known and unknown, uncertainties and other factors that may cause SMIC's actual performance, financial condition or results of operations to be materially different from those suggested by the forward-looking statements, including among others risks associated with the current global economic slowdown, orders or judgments from pending litigation and financial stability in end markets.Investors should consider the information contained in SMIC's filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 20-F filed with the SEC on April 27, 2012, especially in the "Risk Factors Related to Our Financial Condition and Business" and "Operating and Financial Review and Prospects" sections, and such other documents that SMIC may file with the SEC or the Hong Kong Stock Exchange from time to time, including current reports on Form 6-K.  Other unknown or unpredictable factors also could have material adverse effects on SMIC's future results, performance or achievements.  In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed in this press release may not occur.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date of this press release.  Except as may be required by law, SMIC undertakes no obligation and does not intend to update any forward-looking statement, whether as a result of new information, future events or otherwise.  SMIC Contact Information:English Media Anny LiaoTel: +86-21-3861-0000 x16036Email: Anny_Liao@smics.com Chinese Media Angela MiaoTel: +86-21-3861-0000 x10088Email: Angela_Miao@smics.com

SOURCE Semiconductor Manufacturing International Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs